Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xueying Zhao

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 15, 2009
Prevention of local lipotoxicity: a new renoprotective mechanism of peroxisome proliferator-activated receptor-alpha activation in hypertension and obesity?Xueying Zhao
Molecules (Basel, Switzerland)|August 29, 2024
Recent Research Progress on the Chemical Constituents, Pharmacology, and Pharmacokinetics of <i>Alpinae oxyphyllae</i> FructusJunfa Liao, Xueying Zhao
Molecules (Basel, Switzerland)|March 28, 2024
Research Progress on Regulation of Immune Response by Tanshinones and Salvianolic Acids of Danshen (<i>Salvia miltiorrhiza</i> Bunge)Jiawen Tang, Xueying Zhao
Molecules (Basel, Switzerland)|April 14, 2026
Research Progress on the Immunomodulatory Effects by Dang Gui (<i>Radix Angelica sinensis</i>) and Its Active Chemical ComponentsTong Li, Xueying Zhao
Economics and Human Biology|June 28, 2026
Mental health and labour supply: Evidence from ChinaDavid Lander, Xueying Zhao
Natural Product Communications|May 15, 2015
Chemical constituents of the genus Polygonatum and their role in medicinal treatmentXueying Zhao, Ji Li
Molecules (Basel, Switzerland)|August 26, 2022
Review on Chemical Constituents of Schizonepeta tenuifolia Briq. and Their Pharmacological EffectsXueying Zhao, Mingwei Zhou
Bioengineering (Basel, Switzerland)|February 27, 2026
AI and Microfluidics: Unlocking Cellular Motility for BioengineeringXueying Zhao, Beibei Gao
Biotechnology and Bioengineering|June 18, 2022
Escherichia coli chemotaxis to competing stimuli in a microfluidic device with a constant gradientXueying Zhao, Roseanne M Ford
American Journal of Nephrology|February 16, 2008
PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty ratsXueying Zhao, Ling-Yun Li
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 15, 2009
Prevention of local lipotoxicity: a new renoprotective mechanism of peroxisome proliferator-activated receptor-alpha activation in hypertension and obesity?Xueying Zhao
Molecules (Basel, Switzerland)|August 29, 2024
Recent Research Progress on the Chemical Constituents, Pharmacology, and Pharmacokinetics of <i>Alpinae oxyphyllae</i> FructusJunfa Liao, Xueying Zhao
Molecules (Basel, Switzerland)|March 28, 2024
Research Progress on Regulation of Immune Response by Tanshinones and Salvianolic Acids of Danshen (<i>Salvia miltiorrhiza</i> Bunge)Jiawen Tang, Xueying Zhao
Molecules (Basel, Switzerland)|April 14, 2026
Research Progress on the Immunomodulatory Effects by Dang Gui (<i>Radix Angelica sinensis</i>) and Its Active Chemical ComponentsTong Li, Xueying Zhao
Economics and Human Biology|June 28, 2026
Mental health and labour supply: Evidence from ChinaDavid Lander, Xueying Zhao
Natural Product Communications|May 15, 2015
Chemical constituents of the genus Polygonatum and their role in medicinal treatmentXueying Zhao, Ji Li
Molecules (Basel, Switzerland)|August 26, 2022
Review on Chemical Constituents of Schizonepeta tenuifolia Briq. and Their Pharmacological EffectsXueying Zhao, Mingwei Zhou
Bioengineering (Basel, Switzerland)|February 27, 2026
AI and Microfluidics: Unlocking Cellular Motility for BioengineeringXueying Zhao, Beibei Gao
Biotechnology and Bioengineering|June 18, 2022
Escherichia coli chemotaxis to competing stimuli in a microfluidic device with a constant gradientXueying Zhao, Roseanne M Ford
American Journal of Nephrology|February 16, 2008
PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty ratsXueying Zhao, Ling-Yun Li
Pageof 19